文献速递生殖医学

胚胎培养液外泌体hsa-miR-375-3p作为IVF后活产的无创预测生物标志物

hsa-miR-375-3p in embryo culture medium exosomes as a preimplantation non-invasive biomarker for predicting live birth after IVF.
PubMed 文献 · Reprod Biomed Online · 2026-01-16

该研究前瞻性收集单中心5个月内IVF单胚胎移植后妊娠成功(活产,n=34)或失败(n=33)的1级八细胞期胚胎的废弃培养液,分离外泌体并行小RNA测序。qRT-PCR验证显示成功妊娠组外泌体中hsa-miR-375-3p和hsa-miR-215-5p表达更高,ROC分析提示hsa-miR-375-3p(AUC=0.763,灵敏度85%,特异度70%)是胚胎质量的潜在标志物。小鼠胚胎显微注射miR-375-3p抑制剂显著降低八细胞期胚胎形成率(P=0.0358)。

要点

  • 胚胎培养液外泌体hsa-miR-375-3p与IVF后活产相关,AUC=0.763。
  • 成功妊娠组外泌体hsa-miR-375-3p和hsa-miR-215-5p表达更高。
  • 抑制miR-375-3p降低小鼠八细胞期胚胎形成率(P=0.0358)。

核心结论

  • 胚胎废弃培养液外泌体中的hsa-miR-375-3p是IVF后活产的无创预测生物标志物。
  • miR-375-3p对胚胎四细胞到八细胞期转变至关重要。

研究设计与样本

  • 前瞻性收集单中心5个月内IVF单胚胎移植的1级八细胞期胚胎废弃培养液,活产组n=34,失败组n=33。
  • 采用沉淀法分离外泌体,行高通量小RNA测序分析miRNA、tRF和piRNA。
  • 对差异表达miRNA行qRT-PCR验证和ROC分析,并将miR-375-3p抑制剂显微注射入小鼠胚胎评估发育影响。

主要发现

  • 单颗粒免疫荧光证实分离的外泌体表达CD63、CD9和CD81。
  • 外泌体小RNA测序鉴定出51个miRNA、547个piRNA和39个tRF,其中分别有5、11和8个差异表达。
  • qRT-PCR验证显示成功妊娠组废弃培养液外泌体中hsa-miR-375-3p和hsa-miR-215-5p表达高于失败组。
  • ROC分析显示hsa-miR-375-3p的AUC=0.763,灵敏度85%,特异度70%。
  • 抑制miR-375-3p显著降低小鼠八细胞期胚胎形成率(P=0.0358)。

关键数值与推荐

  • hsa-miR-375-3p预测活产的ROC曲线AUC=0.763,灵敏度85%,特异度70%。
  • 抑制miR-375-3p后小鼠八细胞期胚胎形成率下降,P=0.0358。

临床怎么用

  • 可探索将胚胎废弃培养液外泌体hsa-miR-375-3p作为IVF后活产的无创预测指标。
  • 该指标有望为基于miRNA的预测模型奠定基础以改善IVF结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Can non-coding RNAs in exosomes from IVF embryo culture media serve as non-invasive markers for evaluating embryo quality? DESIGN: Spent culture medium (SCM) was prospectively collected from grade 1 eight-cell-stage embryos that resulted in pregnancy success (defined as live birth, n = 34) or failure (n = 33) among patients who underwent IVF and single embryo transfer at a single centre over 5 months. Exosomes were isolated by precipitation, followed by high-throughput small RNA sequencing to profile exosomal non-coding RNAs, including miRNAs, tRFs and piRNAs. The diagnostic potential of validated differentially expressed miRNAs was then evaluated by receiver operating characteristic (ROC) analysis. Specific inhibitors targeting differentially expressed miRNAs were designed and microinjected into mouse embryos to assess their effects on embryonic development. RESULTS: Single-particle immunofluorescence analysis confirmed the presence of exosome-specific markers (CD63, CD9 and CD81) in isolated exosomes. Small RNA sequencing of exosomes identified 51 miRNAs, 547 piRNAs, and 39 tRFs, among which five, 11 and eight were differentially expressed, respectively. Validated by qRT-PCR, expression of hsa-miR-375-3p and hsa-miR-215-5p in SCM-derived exosomes was higher in the successful pregnancy group than in the pregnancy failure group. The ROC curve analysis indicated that hsa-miR-375-3p (AUC = 0.763, sensitivity 85%, specificity 70%) is a potential marker of embryo quality, laying the foundation for a miRNA-based predictive model to improve IVF outcomes. Inhibition of miR-375-3p significantly reduced the eight-cell mouse embryo formation rate (P = 0.0358). CONCLUSIONS: hsa-miR-375-3p in exosomes from SCM of embryos is a non-invasive predictive biomarker of live birth after IVF. miR-375-3p is critical for embryonic development during the four- to eight-cell stage transition.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Zhang L, Mahemuti M, Yakupu Z, et al. hsa-miR-375-3p in embryo culture medium exosomes as a preimplantation non-invasive biomarker for predicting live birth after IVF. Reprod Biomed Online. 2026. PMID: 42400996. doi:10.1016/j.rbmo.2026.105477

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。